Cargando…
Evaluating L1CAM expression in human endometrial cancer using qRT-PCR
BACKGROUND: Management of endometrial carcinoma (EC) still needs improvement of risk assessment. Recently, L1CAM immunohistochemical (IHC) evaluation showed a unique value to predict the outcome of early EC. However IHC results are often conflicting for lack of inter-laboratory standardisation. METH...
Autores principales: | Notaro, Sara, Reimer, Daniel, Duggan-Peer, Michaela, Fiegl, Heidi, Wiedermair, Annamarie, Rössler, Julia, Altevogt, Peter, Marth, Christian, Zeimet, Alain Gustave |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5130004/ https://www.ncbi.nlm.nih.gov/pubmed/27233077 http://dx.doi.org/10.18632/oncotarget.9574 |
Ejemplares similares
-
Evaluation of folate receptor 1 (FOLR1) mRNA expression, its specific promoter methylation and global DNA hypomethylation in type I and type II ovarian cancers
por: Notaro, Sara, et al.
Publicado: (2016) -
Expression and promotor hypermethylation of miR-34a in the various histological subtypes of ovarian cancer
por: Schmid, Gabriel, et al.
Publicado: (2016) -
Clinical impact of L1CAM expression measured on the transcriptome level in ovarian cancer
por: Azim, Samira Abdel, et al.
Publicado: (2016) -
Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2013) -
Correction to: Epigenetic regulation of L1CAM in endometrial carcinoma: comparison to cancer–testis (CT-X) antigens
por: Schirmer, Uwe, et al.
Publicado: (2018)